200 related articles for article (PubMed ID: 20375808)
41. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
42. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
43. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.
Cox JT; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2003 Jun; 188(6):1406-12. PubMed ID: 12824970
[TBL] [Abstract][Full Text] [Related]
44. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
45. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LC; Cuzick J; Myers O; Castle PE; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
[TBL] [Abstract][Full Text] [Related]
46. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.
Bergeron C; Giorgi-Rossi P; Cas F; Schiboni ML; Ghiringhello B; Dalla Palma P; Minucci D; Rosso S; Zorzi M; Naldoni C; Segnan N; Confortini M; Ronco G
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25568167
[TBL] [Abstract][Full Text] [Related]
47. Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.
Castle PE; Qiao YL; Zhao FH; Chen W; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Jeronimo J
BJOG; 2014 May; 121(6):739-46. PubMed ID: 24575872
[TBL] [Abstract][Full Text] [Related]
48. Visual inspection with acetic acid as a feasible screening test for cervical neoplasia in Iran.
Ghaemmaghami F; Behtash N; Modares Gilani M; Mousavi A; Marjani M; Moghimi R
Int J Gynecol Cancer; 2004; 14(3):465-9. PubMed ID: 15228419
[TBL] [Abstract][Full Text] [Related]
49. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
[TBL] [Abstract][Full Text] [Related]
50. Optical coherence tomography for the diagnosis of cervical intraepithelial neoplasia.
Gallwas JK; Turk L; Stepp H; Mueller S; Ochsenkuehn R; Friese K; Dannecker C
Lasers Surg Med; 2011 Mar; 43(3):206-12. PubMed ID: 21412804
[TBL] [Abstract][Full Text] [Related]
51. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
[TBL] [Abstract][Full Text] [Related]
52. Regardless of skill, performing more biopsies increases the sensitivity of colposcopy.
Pretorius RG; Belinson JL; Burchette RJ; Hu S; Zhang X; Qiao YL
J Low Genit Tract Dis; 2011 Jul; 15(3):180-8. PubMed ID: 21436729
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of cytology and visual triage of human papillomavirus-positive women in cervical cancer prevention in India.
Muwonge R; Wesley RS; Nene BM; Shastri SS; Jayant K; Malvi SG; Thara S; Sankaranarayanan R
Int J Cancer; 2014 Jun; 134(12):2902-9. PubMed ID: 24272364
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
56. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
57. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
[TBL] [Abstract][Full Text] [Related]
58. Optical coherence tomography as a non-invasive imaging technique for preinvasive and invasive neoplasia of the uterine cervix.
Gallwas J; Turk L; Friese K; Dannecker C
Ultrasound Obstet Gynecol; 2010 Nov; 36(5):624-9. PubMed ID: 20503239
[TBL] [Abstract][Full Text] [Related]
59. Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia.
Adamopoulou M; Kalkani E; Charvalos E; Avgoustidis D; Haidopoulos D; Yapijakis C
Anticancer Res; 2009 Aug; 29(8):3401-9. PubMed ID: 19661364
[TBL] [Abstract][Full Text] [Related]
60. Description of patients with squamous cell carcinoma in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study.
Atkins KA; Jeronimo J; Stoler MH;
Cancer; 2006 Aug; 108(4):212-21. PubMed ID: 16680733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
